CannFX

CannFX is a New Zealand-based medicinal cannabis company that focuses on the development, manufacturing, and distribution of pharmaceutical-grade cannabinoid products. The company operates under the New Zealand Medicinal Cannabis Scheme, ensuring that its products meet strict quality standards for potency and purity. CannFX provides a range of oral liquid formulations, including high-CBD, high-THC, and balanced CBD:THC products, primarily targeting chronic pain, anxiety, and sleep disorders. By leveraging strategic partnerships for cultivation and extraction, the company maintains a consistent supply of standardized therapeutics for the domestic and international markets. CannFX is committed to advancing the clinical understanding of cannabis through patient-focused research and healthcare professional education.